Position
Chief Financial Officer
Company
Fore Biotherapeutics
PhiladelphiaBiotechnologyHealth CareTherapeuticsDescription
FORE Biotherapeutics has appointed Michael Byrnes as the new Chief Financial Officer. Mr. Byrnes brings over 20 years’ experience in the biotechnology industry and has a background and track record in both private and public companies.
Quick answer
FORE Biotherapeutics Appoints Michael Byrnes as Chief Financial Officer (August 12, 2024). Fore Biotherapeutics is based in Philadelphia, Pennsylvania, United States.
- Who is the new Chief Financial Officer at Fore Biotherapeutics?
- Fore Biotherapeutics named Michael Byrnes Chief Financial Officer, announced August 12, 2024.
- What did Fore Biotherapeutics announce on August 12, 2024?
- FORE Biotherapeutics has appointed Michael Byrnes as the new Chief Financial Officer. Mr. Byrnes brings over 20 years’ experience in the biotechnology industry and has a background and track record in both private and public companies.
- What does Fore Biotherapeutics do?
- Fore Bio is a precision oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat cancers.
- Where is Fore Biotherapeutics based?
- Fore Biotherapeutics is based in Philadelphia, Pennsylvania, United States.
- Which similar companies made leadership changes around the same time?
- Pathalys Pharma (August 13, 2024), Signal12 (August 13, 2024), Pfizer (August 13, 2024) and Oculis Holding AG (August 15, 2024) also announced leadership changes within 45 days of Fore Biotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pathalys Pharma Appoints Bastian Dehmel, M.D. as Chief Medical Officer (August 13, 2024)
- Thomas Mitro Named President & Chief Executive Officer of Signal12 Inc. (August 13, 2024)
- Pfizer Appoints Berta Rodriguez-Hervas as Chief AI and Analytics Officer (August 13, 2024)
- Oculis Appoints Dr. Sharon Klier as Chief Development Officer (August 15, 2024)
- Exicure, Inc. Appoints Anna Chukaeva as Senior Vice President, Head of Corporate Development and Bioinformatics (August 8, 2024)
- Intra-Cellular Therapies Appoints Sanjeev Narula as Executive Vice President, Chief Financial Officer (August 8, 2024)
Who to call at Fore Biotherapeutics, and when
A new leader at Fore Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Fore Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Fore Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Fore Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Fore Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Fore Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.